B and T cell-targeting drug ameliorates chronic graft-versus-host disease in mice

Hematopoietic stem cells can differentiate into all types of blood cells, including red blood cells and immune cells. While HSC transplantation can be life saving for patients with aggressive forms of blood cancer that are unresponsive to other available treatments, there are many risks associated with the procedure.

http://ift.tt/YOQmUr